MedPath

The effect of nebulized lidocaine 2% in patients sedation during awake intubatio

Phase 3
Recruiting
Conditions
Inhalation sedation.
Inhaled anaesthetics
Registration Number
IRCT20180806040724N2
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
55
Inclusion Criteria

Patients who candidates undergoing awake intubation
History of difficult intubations
Patients over 14 years and below 70 years

Exclusion Criteria

Lack of cooperation (if the awake intubation is not essential)
History of liver and kidney disease and coagulation
Pathology of the respiratory tract
Pregnancy
Patients who have long received opioid or sedative medications
Aspiration and regurgitation probability

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depth of sedation. Timepoint: 3 minutes after sedation with midazolam and 10 minutes after inhalation of lidocaine nebulizer 2%. Method of measurement: Bispecteral (BIS) index.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath